1
|
Mejia A, Smith GD, Curiel RE, Barker W, Behar R, Armstrong MJ. Value Assessment in Healthcare Decision-Making of Ethnically and Cognitively Diverse Older Adults. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz029.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
Little is known regarding the values that patients with mild cognitive impairment (MCI) incorporate into healthcare decision-making or how culture may affect such values. Even if values overlap across cultures, cultural groups may emphasize the importance of specific values differently since values emanate, at least in part, from cultural and life-long learning. The aim of this study was to explore and compare values that older adults of different ethnicities and cognitive statuses incorporate in their medical decisions.
Participants and Method
Four focus groups were established by identifying older adults as, a) Hispanic or non-Hispanic, and with b) normal cognition or MCI. Participants were recruited from the 1Florida Alzheimer’s Disease Research Center. Focus groups were audio-recorded and transcribed using a professional transcription service.
Results
There were a total of 23 participants (Age: M = 70.9, SD = 6.4). MCI groups had briefer discussions (Time M = 44 minutes) than the normal cognition groups (Time M = 62 minutes). Qualitative analysis of discussions was used to explore the values identified across the focus groups. The MCI groups valued spirituality, doctor recommendations, and family involvement when facing medical decisions. Normal cognition groups valued the necessity of proactive involvement as healthcare consumers and the relationship between the quality of patient-clinician interaction and their health care related decisions. Cultural themes involving perceptions of gender and generational differences emerged from the Hispanic normal cognition group.
Conclusions
This study identified many determinants influencing the medical decision-making process of diverse older adults: including past experiences, family involvement, healthcare barriers, and cultural background. These results have the potential to impact patient-clinician discussions, decisions made by surrogates, and the development of decision aids with a broader range of relevant patient values.
Collapse
|
2
|
Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, Rosselli M, Penate A, Shea YF, Behar R, Ollarves A, Robayo C, Hanson K, Marsiske M, Burke S, Ertekin-Taner N, Vaillancourt D, De Santi S, Golde T, St D. Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity. Neuroimage Clin 2019; 22:101800. [PMID: 30991618 PMCID: PMC6447735 DOI: 10.1016/j.nicl.2019.101800] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/22/2018] [Revised: 02/08/2019] [Accepted: 03/26/2019] [Indexed: 11/30/2022]
Abstract
The threshold for amyloid positivity by visual assessment on PET has been validated by comparison to amyloid load measured histopathologically and biochemically at post mortem. As such, it is now feasible to use qualitative visual assessment of amyloid positivity as an in-vivo gold standard to determine those factors which can modify the quantitative threshold for amyloid positivity. We calculated quantitative amyloid load, measured as Standardized Uptake Value Ratios (SUVRs) using [18-F]florbetaben PET scans, for 159 Hispanic and non-Hispanic participants, who had been classified clinically as Cognitively Normal (CN), Mild Cognitive Impairment (MCI) or Dementia (DEM). PET scans were visually rated as amyloid positive (A+) or negative (A-), and these judgments were used as the gold standard with which to determine (using ROC analyses) the SUVR threshold for amyloid positivity considering factors such as age, ethnicity (Hispanic versus non-Hispanic), gender, cognitive status, and apolipoprotein E ε4 carrier status. Visually rated scans were A+ for 11% of CN, 39.0% of MCI and 70% of DEM participants. The optimal SUVR threshold for A+ among all participants was 1.42 (sensitivity = 94%; specificity = 92.5%), but this quantitative threshold was higher among E4 carriers (SUVR = 1.52) than non-carriers (SUVR = 1.31). While mean SUVRs did not differ between Hispanic and non-Hispanic participants;, a statistically significant interaction term indicated that the effect of E4 carrier status on amyloid load was greater among non-Hispanics than Hispanics. Visual assessment, as the gold standard for A+, facilitates determination of the effects of various factors on quantitative thresholds for amyloid positivity. A continuous relationship was found between amyloid load and global cognitive scores, suggesting that any calculated threshold for the whole group, or a subgroup, is artefactual and that the lowest calculated threshold may be optimal for the purposes of early diagnosis and intervention. Demographic factors did not affect the threshold for amyloid positivity. Cognitive status did not affect this threshold for amyloid positivity. APOE4 carriers had a higher threshold for amyloid positivity than non-carriers. Among APOE4 carriers, non-Hispanics had higher amyloid load than non- Hispanics. There was a continuous relationship between amyloid load and cognitive status.
Collapse
Affiliation(s)
- R Duara
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA; College of Engineering and Computing, Florida International University, Miami, FL, USA; University of Florida College of Medicine, Gainesville, FL, USA.
| | - D A Loewenstein
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA; Miller School of Medicine, University of Miami, Miami, FL, USA
| | - G Lizarraga
- Florida ADRC, USA; College of Engineering and Computing, Florida International University, Miami, FL, USA
| | - M Adjouadi
- Florida ADRC, USA; College of Engineering and Computing, Florida International University, Miami, FL, USA
| | - W W Barker
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA
| | - M T Greig-Custo
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA
| | - M Rosselli
- Florida ADRC, USA; Florida Atlantic University, USA
| | - A Penate
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA
| | - Y F Shea
- Mount Sinai Medical Center, Miami Beach, USA; Department of Medicine, University of Hong Kong, Hong Kong
| | - R Behar
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA
| | - A Ollarves
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA
| | - C Robayo
- Florida ADRC, USA; Mount Sinai Medical Center, Miami Beach, USA
| | - K Hanson
- Florida ADRC, USA; University of Florida College of Medicine, Gainesville, FL, USA
| | - M Marsiske
- Florida ADRC, USA; University of Florida College of Medicine, Gainesville, FL, USA; University of Florida, College of Public Health and Health Professions, USA
| | - S Burke
- Florida ADRC, USA; Robert Stempel College of Public Health & Social Work, Florida International University, Miami, FL, USA
| | - N Ertekin-Taner
- Mayo Clinic Florida, Department of Neurology, Jacksonville, FL, USA; Mayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA
| | - D Vaillancourt
- Florida ADRC, USA; University of Florida College of Medicine, Gainesville, FL, USA
| | | | - T Golde
- Florida ADRC, USA; University of Florida College of Medicine, Gainesville, FL, USA
| | - DeKosky St
- Florida ADRC, USA; University of Florida College of Medicine, Gainesville, FL, USA
| |
Collapse
|
3
|
Lai C, August S, Albibas A, Behar R, Cho SY, Polak ME, Theaker J, MacLeod AS, French RR, Glennie MJ, Al-Shamkhani A, Healy E. OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential. Clin Cancer Res 2016; 22:4236-48. [PMID: 27034329 PMCID: PMC4987192 DOI: 10.1158/1078-0432.ccr-15-2614] [Citation(s) in RCA: 65] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2015] [Accepted: 03/18/2016] [Indexed: 12/31/2022]
Abstract
PURPOSE Cutaneous squamous cell carcinoma (cSCC) is the most common human cancer with metastatic potential. Despite T cells accumulating around cSCCs, these tumors continue to grow and persist. To investigate reasons for failure of T cells to mount a protective response in cSCC, we focused on regulatory T cells (Tregs) as this suppressive population is well represented among the infiltrating lymphocytes. EXPERIMENTAL DESIGN Flow cytometry was conducted on cSCC lymphocytes and in vitro functional assays were performed using sorted tumoral T cells. Lymphocyte subsets in primary cSCCs were quantified immunohistochemically. RESULTS FOXP3(+) Tregs were more frequent in cSCCs than in peripheral blood (P < 0.0001, n = 86 tumors). Tumoral Tregs suppressed proliferation of tumoral effector CD4(+) (P = 0.005, n = 10 tumors) and CD8(+) T cells (P = 0.043, n = 9 tumors) and inhibited IFNγ secretion by tumoral effector T cells (P = 0.0186, n = 11 tumors). The costimulatory molecule OX40 was expressed predominantly on tumoral Tregs (P < 0.0001, n = 15 tumors) and triggering OX40 with an agonist anti-OX40 antibody overcame the suppression exerted by Tregs, leading to increased tumoral effector CD4(+) lymphocyte proliferation (P = 0.0098, n = 10 tumors). Tregs and OX40(+) lymphocytes were more abundant in primary cSCCs that metastasized than in primary cSCCs that had not metastasized (n = 48 and n = 49 tumors, respectively). CONCLUSIONS Tregs in cSCCs suppress effector T-cell responses and are associated with subsequent metastasis, suggesting a key role for Tregs in cSCC development and progression. OX40 agonism reversed the suppressive effects of Tregs in vitro, suggesting that targeting OX40 could benefit the subset of cSCC patients at high risk of metastasis. Clin Cancer Res; 22(16); 4236-48. ©2016 AACR.
Collapse
Affiliation(s)
- Chester Lai
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
| | - Suzannah August
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
| | - Amel Albibas
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Ramnik Behar
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Shin-Young Cho
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Marta E Polak
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Jeffrey Theaker
- Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
| | - Amanda S MacLeod
- Dermatology, Duke University Medical Center, Durham, North Carolina
| | - Ruth R French
- Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Martin J Glennie
- Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Aymen Al-Shamkhani
- Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| | - Eugene Healy
- Dermatopharmacology, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
| |
Collapse
|
4
|
Lai C, August S, Behar R, Polak M, Ardern-Jones M, Theaker J, Al-Shamkhani A, Healy E. Characteristics of immunosuppressive regulatory T cells in cutaneous squamous cell carcinomas and role in metastasis. Lancet 2015; 385 Suppl 1:S59. [PMID: 26312881 DOI: 10.1016/s0140-6736(15)60374-9] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
BACKGROUND Non-melanoma skin cancer is the most common cancer worldwide, and cutaneous squamous cell carcinomas (SCCs) account for substantial morbidity and mortality because of their potential for metastasis. SCCs are surrounded by an immune cell infiltrate containing regulatory T cells (Tregs). The aim of this study was to characterise Tregs in SCCs and investigate whether increased Treg numbers in primary skin SCCs are associated with subsequent metastasis. METHODS Lymphocytes were extracted from freshly excised skin SCC tumours and corresponding peripheral blood and normal skin. Flow cytometry was used for T-cell analysis and cell sorting. Tritiated thymidine based lymphocyte proliferation assays and interferon γ (IFNγ) ELISPOT assays were used to assess peritumoral lymphocyte function in vitro. Immunohistochemistry was performed on primary cutaneous SCC sections from tumours that subsequently metastasised and from those that did not after 5-year follow-up. FINDINGS Increased frequencies of CD3+CD4+CD25hiCD127loFOXP3+ Tregs were found in SCCs (21·5% of CD4+ immune infiltrate, n=60 tumours) compared with corresponding peripheral blood (5·4%) and normal skin (7·6%). SCC Tregs expressed significantly higher levels of the co-stimulatory molecules OX40 (37·2% of FOXP3+ cell population, n=10 tumours) and 4-1BB (12·6%, n=9) than peritumoral non-regulatory T cells and Tregs from peripheral blood and normal skin (p=0·0005). The inhibitory receptor CTLA4 and the transcription factor Helios were expressed at high levels in peritumoral Tregs. SCC Tregs significantly suppressed phytohaemagglutinin-stimulated peritumoral CD4+ T-cell proliferation (p=0·005, n=10), peritumoral CD8+ T-cell proliferation (p=0·015, n=9), and IFNγ secretion by CD4+ effector T cells (p=0·026, n=10). Increased in-vitro proliferation of phytohaemagglutinin-stimulated peritumoral CD4+ T cells was shown after the addition of anti-OX40 antibodies (p=0·0078, n=9 tumours) and anti-4-1BB antibodies (p=0·0039, n=9). Immunohistochemistry showed fewer CD8+ T cells in SCCs that metastasised (n=29) than in non-metastatic SCCs (n=26) (28·5% of immune infiltrate vs 44·6%%, p<0·0001) and more FOX3+ Tregs (28·5% of immune infiltrate vs 49·3%, p<0·0001). INTERPRETATION Our study shows that immunosuppressive Tregs are present in the immune infiltrate of cutaneous SCCs, and contribute to ineffective anti-tumour immune responses, thereby permitting SCC development and promoting metastasis. FUNDING Wellcome Trust, National Institute for Health Research.
Collapse
Affiliation(s)
- Chester Lai
- Dermatopharmacology, University of Southampton, Southampton, UK.
| | - Suzannah August
- Dermatopharmacology, University of Southampton, Southampton, UK
| | - Ramnik Behar
- Dermatopharmacology, University of Southampton, Southampton, UK
| | - Marta Polak
- Dermatopharmacology, University of Southampton, Southampton, UK
| | | | - Jeff Theaker
- Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | | | - Eugene Healy
- Dermatopharmacology, University of Southampton, Southampton, UK
| |
Collapse
|
5
|
Jabboury KW, Wong A, Sexton K, Rogers L, King K, Reilly C, Thomas S, Curtis P, Mangini O, Behar R. Limited impact of tamoxifen following dose-intensive L-FAC multimodality therapy of breast cancer. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.10741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10741 Background: Front-line dose-intensive L-FAC has demonstrated a favorable 5-year relapse free survival pattern (ASCO 2004 #739). Tamoxifen was given for 5 years to ER+ patients after L-FAC completion. We evaluated the impact of adding tamoxifen to L-FAC. By design, this pilot study excluded low-risk patients not candidates for chemotherapy. Methods: 109 breast cancer patients were enrolled (4 excluded due to treatment violations) from 6/1989 to 1/2003: 20 Stage I (S), 52 S-II, 22 S-III, for a total of 94 patients. 11 S-IV patients were excluded from survival analysis. Adverse tumor presentations included: ER- 49, PgR- 60, P53+ 24, non-diploid 39, histological grade III 37, CerbB2+ 33. L-FAC included 72 hour (h) iv infusion 400mg/m2/day (d) 5-fluorouracil (F) modulated by iv bolus 200mg/m2/d X3 leucovorin (L), concomitantly with 24h iv d1 600–1000mg/m2 cyclophosphamide (C), 48h iv d2 + d3 60mg/m2 doxorubicin (A). S-I and S-II were given 6 courses and 8 for S-III. Increasing A + C dose level and/or shortening treatment intervals < 3 weeks with growth factors provided intensification. 40 patients received tamoxifen. Results: At a median follow-up of 74 months (range 9–214), 73 (78%) are alive (1 with relapse). Relapse free survival was: S-I 95%, S-II 81%, S-III 78%. At average course intervals of 18 days, dose intensity A/C mg/m2/wk was 24.2 / 335.4 with evidence of WHO grade III/IV stomatitis in 43%, neutropenia 59%, cumulative thrombocytopenia 50%, hand-foot syndrome 32% of patients. Aside from delayed relapse associated with tamoxifen, relapse-free survival >82 months was similar with and without tamoxifen. No relapse was observed after >53 months in ER- tumors despite showing higher frequency of adverse tumor risk factors. Conclusion: The impact of adding tamoxifen appears quite limited in a patient population with adverse tumor presentation treated with dose-intensive L-FAC. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- K. W. Jabboury
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - A. Wong
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - K. Sexton
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - L. Rogers
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - K. King
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - C. Reilly
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - S. Thomas
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - P. Curtis
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - O. Mangini
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| | - R. Behar
- Jabboury Foundation for Cancer Research, Inc., Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX; Spring Branch Medical Center, Houston, TX
| |
Collapse
|
6
|
Jabboury K, Wong A, Deutsch A, Behar R, King K, Thomas S, Reilly C, Curtis P, Mangini O. 5-year survival with dose intensive L-FAC multimodality therapy of breast cancer. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- K. Jabboury
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - A. Wong
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - A. Deutsch
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - R. Behar
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - K. King
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - S. Thomas
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - C. Reilly
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - P. Curtis
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| | - O. Mangini
- Jabboury Foundation for Cancer Research, Inc, Houston, TX; Spring Branch Medical Center, Houston, TX; Sugar Land Cancer Center, Sugar Land, TX; West Houston Medical Center, Houston, TX
| |
Collapse
|
7
|
Behar R, de la Barrera M, Michelotti J. [Gender identity and eating disorders]. Rev Med Chil 2001; 129:1003-11. [PMID: 11725463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
BACKGROUND A possible role of the feminine gender role in the genesis of eating disorders is possible, since most patients with these disorders are women. AIM To compare some traits of gender identity between females with eating disorders and a control group. MATERIAL AND METHODS An structured clinical interview based on the DSM-IV diagnostic criteria for eating disorders and the Bem Sex Role Inventory (BSRI) were administered to 63 patients that fulfilled the DSM-IV criteria for anorexia nervosa or bulimia nervosa (ED group) and 63 comparison subjects (C group). RESULTS Forty three percent of patients in contrast with 23.8% of controls were classified within the feminine category. Likewise 19% of patients and 31.7% of controls were qualified as Androgynous; 27% of patients and 43% of controls were qualified as Undifferentiated. There were significant differences between patients and controls in 22 items of the BSRI (p < 0.01). Both groups rejected and were identified with some feminine, masculine and neutral qualities. DISCUSSION Femininity emerged as the main trait of gender identity in patients suffering of eating disorders. In contrast, Androgyny showed by the control group could result in a better adaptability and flexibility to face difficult life circumstances.
Collapse
Affiliation(s)
- R Behar
- Departamento de Psiquiatría, Universidad de Valparaíso, Valparaíso, Chile.
| | | | | |
Collapse
|
8
|
Sharkey J, Chovnick S, Behar R, Otheguy J, Rabinowitz R. Re: Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 2001; 165:192-3. [PMID: 11125403 DOI: 10.1097/00005392-200101000-00054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
9
|
Behar R. [Eating disorders in adolescents: clinical and epidemiological aspects]. Rev Med Chil 1998; 126:1085-92. [PMID: 9922512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
OBJECTIVE To compare in female adolescents clinical and epidemiological aspects of eating disorders. METHODS Three hundred schoolgirls, university students and young girls with weight problems who did not score within the pathological range of the Eating attitudes test (EAT-40) (group S), one hundred and thirty eight schoolgirls, university students and young girls with weight problems who scored within the pathological range of the EAT-40 (group SC) and one hundred eating disordered patients (group THC) were given the Eating disorders inventory (EDI). RESULTS The EAT-26 emerged as an abbreviated and trustful instrument. The scores on the EAT-40 and EDI were lower in group S, intermedial in group SC and higher in group THC. The same statistically significant differences (p < 0.001) were observed on Interoceptive awareness. Bulimia, Ineffectiveness and Maturity fears. Diet (EAT-40-Factor I) (90%) and EDI-Drive for thinness (87%) had the highest sensitivity. CONCLUSIONS The EAT-26, EAT-40 and EDI were useful to confirm an eating disorder. On one hand, the profile of the eating disordered patients and the adolescents at risk was characterized by a high Drive for thinness and Body dissatisfaction and on the other, by a low Interoceptive awareness. Diet and Drive for thinness may be helpful for screening large non-clinical groups to predict an eating disorder. Finally, the importance of the nutrition assessment and primary prevention is emphasized.
Collapse
Affiliation(s)
- R Behar
- Departamento de Psiquiatría, Universidad de Valparaíso, Chile
| |
Collapse
|
10
|
Behar R. Singing the Blue Cross blues. Time 1993; 142:48. [PMID: 10126999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
|
11
|
Behar R. [Gender role and anorexia nervosa]. Acta Psiquiatr Psicol Am Lat 1992; 38:119-22. [PMID: 1305362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The gender role is defined; its physiognomy, adopted by women since the occurrence of the Industrial Revolution, and the intricate status that characterizes the present feminine role are described. Finally, a psychosocial approach of anorexia nervosa is made. This disorder is considered as a paradigm of the present ambiguity of the femininity concept likely to become a transactional phenomenon between sexual identities.
Collapse
Affiliation(s)
- R Behar
- Depto. Psiquiatría, Universidad de Valparaíso, Chile
| |
Collapse
|
12
|
Menken M, Behar R, Lee P. Neurology referral patterns. HMO Pract 1990; 4:57-60. [PMID: 10104284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
To examine the indications for referral of patients to neurologists, a survey was conducted of 88 such referrals by general internists in an HMO. In approximately one third of all referrals, the neurologist's advice regarding diagnosis and treatment was of minor or no importance. Instead, such referrals were often responsive to patient and family demands or focused upon the necessity for neuroimaging, even when the likely diagnosis and required treatment were already evident. Referral rates in HMO practice are strongly influenced by the practice styles of primary care providers. The authors conclude that a case manager ("gatekeeper") mechanism in competitive medical plans that excludes patient self-referrals may have a greater effect upon total (and surgical) specialty care, compared with the volume of services provided by medical specialists such as neurologists.
Collapse
Affiliation(s)
- M Menken
- Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey
| | | | | |
Collapse
|
13
|
Abstract
A 34-year-old homosexual man with acquired immune deficiency syndrome developed extraocular muscle deficits, chorioretinitis, and paraplegia without sensory symptoms. EMG showed severe diffuse denervation, but only mildly slowed nerve conduction velocities, in both legs. Meningitis persisted for 6 weeks and was exacerbated prior to the patient's death. Necropsy revealed subpial and subependymal cytomegalovirus (CMV) infection. Histology of ventral roots demonstrated proximal CMV infection and massive fiber loss. In this immunosuppressed patient, CMV caused a severe motor polyradiculopathy by selective destruction of the motor neurons of ventral spinal roots and motor cranial nerves.
Collapse
|
14
|
Bentur Y, Brook JG, Behar R, Taitelman U. Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning. J Toxicol Clin Toxicol 1987; 25:39-51. [PMID: 3035204 DOI: 10.3109/15563658708992612] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Lead poisoning remains one of the hazards of industrialized civilization. CaNa2 EDTA and dimercaprol, the usual therapeutic measures, have many side effects and can be given by parenteral route alone. The authors present a case of chronic lead poisoning caused by ingestion of contaminated flour ground in a primitive flour mill. The diagnosis was confirmed by the CaNa2 EDTA provocative test. Dimercaptosuccinic acid (DMSA) was given orally as a further provocation and resulted in an 11-fold increase in urinary lead excretion. A 5-day course of treatment with DMSA was instituted, during which symptoms abated, urinary lead excretion increased and the blood lead level decreased. No side effects were noticed. There has been no relapse over several months of follow-up. The authors conclude that the oral use of DMSA is effective, safe and convenient both as a provocative test in establishing the diagnosis of lead poisoning and as a therapeutic tool.
Collapse
|
15
|
Behar R, Arganini M, Wu TC, McCormick M, Straus FH, DeGroot LJ, Kaplan EL. Graves' disease and thyroid cancer. Surgery 1986; 100:1121-7. [PMID: 3787468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The relationship between Graves' disease or its therapy and carcinoma of the thyroid remains uncertain. We studied 20 patients found to have thyroid cancer in glands previously treated for Graves' disease between 1961 and 1986 at the University of Chicago Medical Center. Sixteen (80%) occurred in women and four (20%) occurred in men. The mean age at operation was 37 years (range, 19 to 69 years) and did not differ by sex. Fifteen of the 20 cancers (75%) were papillary while five (25%) were follicular. Six individuals (30%) had a history of external radiation to the head and neck as an infant, child, or young adult. Two others had received radioiodine (RAI) therapy for Graves' disease 1 and 19 years earlier. Patients were divided into three groups: group I: four patients (20%) had a neck mass 4, 14, 20, and 41 years after having had a subtotal thyroidectomy (STT) for Graves' disease; three of four had a history of external irradiation therapy. These tumors behaved aggressively, resulting in the death of two of the four patients. group II: 11 patients (55%) had diffusely enlarge toxic goiters without a nodule. A carcinoma was diagnosed intraoperatively on frozen section in only two of these patients. The others received STT. After recognition on permanent section, those carcinomas that were 4 mm or greater in diameter received postoperative RAI. One recurrence occurred and was treated successfully with further RAI. group III: Five patients (25%) had Graves' disease and a palpable thyroid nodule. None of them had had a prior thyroidectomy for Graves' disease, as in group 1. Thyroid carcinoma was diagnosed in all patients preoperatively or intraoperatively, and a total thyroidectomy was performed. Each patient is alive and well with a mean follow-up of 5 years. Between 1971 and 1981, 194 patients had surgery for Graves' disease, and 10 (5.2%) were found to have an associated carcinoma; six patients (3.1% of the total) did not have a nodule or any other suspicion of malignancy before surgery. During the same time, 303 patients received RAI therapy for Graves' disease and one (0.3%) has subsequently developed thyroid carcinoma. Thyroid cancer associated with Graves' disease is found more commonly in surgically treated patients than in patients after RAI therapy. The greatest risk factor in our patients was previous external radiation to the head and neck. Such individuals should be treated with total thyroid ablation rather than the usual STT, since they are at risk of developing aggressive thyroid cancers if thyroid remnants are left.
Collapse
|
16
|
Arganini M, Behar R, Wu TC, Straus F, McCormick M, DeGroot LJ, Kaplan EL. Hürthle cell tumors: a twenty-five-year experience. Surgery 1986; 100:1108-15. [PMID: 3787466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
During a 25-year period (1959 through 1983), 54 patients with Hürthle cell tumors were treated and monitored at the University of Chicago Medical Center. Thirty percent were men and 70% were women; mean age at diagnosis was 46.7 +/- 13.2 years (range: 19 to 69 years). Tumors were grouped into three categories at the time of initial diagnosis: group 1, grossly malignant (four patients, or 7.5%); group 2, intermediate (partial capsular and/or subcapsular vascular invasion) (10 patients, or 18.5%); and group 3, benign appearing (40 patients, or 74%). Twenty-one (39%) of the patients had a history of low-dose, external radiation to the head and neck in childhood (including three of four grossly malignant lesions). A separate non-Hürthle cell thyroid carcinoma was found within the thyroid gland in 22 (50%) of the patients--79% were papillary and 21% were follicular carcinomas. In half of these, there was a history of childhood irradiation. During a mean follow-up period of 8.4 years (range, 22 days to 35 years), three additional Hürthle cell tumors were recognized as malignant after metastases were discovered--two were originally classified as intermediate lesions and one was in the benign-appearing group. Thus, seven of 54 of our patients (13%) had Hürthle cell carcinomas. One of the seven patients died of widespread metastases after 35 years, and the other six are currently free of disease. We believe that therapy of these lesions should be individualized. Total thyroid ablation (surgical procedure followed by radioiodine therapy) is appropriate for frankly malignant Hürthle cell cancers, for all Hürthle cell tumors occurring in patients who received low-dose childhood irradiation, for associated papillary or follicular carcinomas, and in those patients who exhibit partial capsular or subcapsular vascular invasion. On the other hand, single, well-encapsulated, benign-appearing Hürthle cell tumors may be treated by lobectomy and careful follow-up, since the chance that they will later exhibit malignant behavior is low (2.5% in our series and 1.5% among patients described in the recent literature).
Collapse
|
17
|
Abstract
A 73-year-old patient developed tetraplegia, cranial neuropathies and autonomic instability and died of clinical complications of Guillain-Barré syndrome. He was incidentally found to have subclinical Hashimoto's thyroiditis. The literature since 1966 is reviewed for the association of Guillain-Barré syndrome with thyroiditis, other endocrine abnormalities, and some diseases thought to be caused by autoimmune mechanisms.
Collapse
|
18
|
Sgan-Cohen HD, Lipsky R, Behar R. Caries, diet, dental knowledge and socioeconomic variables in a population of 15-year-old Israeli schoolchildren. Community Dent Oral Epidemiol 1984; 12:332-6. [PMID: 6593152 DOI: 10.1111/j.1600-0528.1984.tb01465.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
A population of 163 10th grade, 15-yr-old students of a Jerusalem high school were surveyed for caries prevalence, cariogenic dietary habits, dental knowledge and socioeconomic variables. A mean level of 7.75 DMFT was found, confirming results of previous studies which indicate a general increase of caries prevalence in Israel over the past two decades. None of the independent variables measured constituted significant predictors of caries prevalence. However, father's geographic origin, mother's educational level and social class according to father's occupation demonstrated significant associations with caries treatment levels as expressed by the FT and DT components of the DMFT index.
Collapse
|
19
|
Craig TJ, Behar R. Changes in the prescription of anticholinergic drugs (1970-1977) in a state hospital. Int Pharmacopsychiatry 1981; 16:84-91. [PMID: 6120916 DOI: 10.1159/000468481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
A study of the prescribing patterns of physicians in a state hospital during 1970-1977 revealed a four-fold drop in the use of combinations of drugs with strong anticholinergic properties. This dramatic shift to more rational practices stands in contrast to reports of persistent inappropriate prescribing in other settings. The time pattern of the changes suggests that an active ongoing educational program combined with a drug monitoring system providing feedback to physicians was primarily responsible for the findings. This study clearly documents the fact that physicians' prescribing patterns are amenable to change in the direction of more appropriate practices.
Collapse
|
20
|
Abstract
This study reports an exceptionally high incidence of palatal displacement of maxillary cuspids in the presence of anomalous lateral incisors, and explores some of the relationships between these teeth during the critical developmental stages. It is suggested that the possibility of palatal cuspid displacement be evaluated in all cases with anomalous lateral incisors.
Collapse
|
21
|
|
22
|
Abstract
Renin activity and aldosterone were evaluated relative to potassium levels and lead intoxication in 33 patients with a history of "moonshine" ingestion. Patients were divided into three groups: I, lead intoxicated with hyperkalemia; II, lead intoxicated without hyperkalemia; and III, not lead intoxicated without hyperkalemia. Those in group I demonstrated suppressed plasma renin activity, baseline and after furosemide, and blunted aldosterone responsiveness to furosemide. Plasma renin activity was not different in groups II and III, whereas aldosterone responsiveness was less in group II than in III. Group I patients tended to be older, had lower creatinine clearances, and six of nine had mild hyperchloremic acidosis. Diabetes and cortisol insufficiency were not present. Chronic lead intoxication due to illicit alcohol ingestion is associated with hyporeninemic hypoaldosteronism and hyperkalemia which appear to develop as the lead nephropathy progresses with duration and/or aging.
Collapse
|